Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors

Li, C; Bonazzoli, E; Bellone, S; Choi, J; Dong, Wl; Menderes, G; Altwerger, G; Han, C; Manzano, A; Bianchi, A; Pettinella, F; Manara, P; Lopez, S; Yadav, G; Riccio, F; Zammataro, L; Zeybek, B; Yang-Hartwich, Y; Buza, N; Hui, P; Wong, S; Ravaggi, A; Bignotti, E; Romani, C; Todeschini, P; Zanotti, L; Zizioli, V; Odicino, F; Pecorelli, S; Ardighieri, L; Silasi, Da; Litkouhi, B; Ratner, E; Azodi, M; Huang, Gs; Schwartz, Pe; Lifton, Rp; Schlessinger, J; Santin, Ad